Juvenile Idiopathic Arthritis
Authors:
- 2 January 2024
- journal article
- review article
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 91 (9) , 949-958
Abstract
Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children. The International League of Associations for Rheumatology (ILAR) has defined JIA as “arthritis of unknown etiology persisting for ≥6 wk with an onset at <16 y of age, after excluding other causes of joint inflammation”. Synovial inflammation is the result of a complex interplay of aberrant immune systems (both adaptive and innate) in a genetically susceptible individual, with possible external stimuli/triggers. Diagnosis of JIA essentially remains clinical, and laboratory investigations usually help to assess the severity of disease activity. Few investigations like antinuclear antibodies (ANA), human leukocyte antigen (HLA)-B27, and rheumatoid factor (RF) help to categorize or prognosticate a child with JIA. Timely use of effective therapeutic interventions including biological has shown good long-term outcomes of JIA.Keywords
This publication has 37 references indexed in Scilit:
- The role of the circadian clock in rheumatoid arthritisArthritis Research & Therapy, 2013
- Systemic juvenile idiopathic arthritisAutoimmunity Reviews, 2012
- 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic featuresArthritis Care & Research, 2011
- Profile of Indian Patients with Juvenile Onset Chronic Inflammatory Joint Disease Using the ILAR Classification Criteria for JIA: A Community-based Cohort StudyThe Journal of Rheumatology, 2010
- Clinical and articular presentation of juvenile idiopathic arthritisPediatric Rheumatology, 2008
- Efficacy of thalidomide in systemic onset juvenile rheumatoid arthritisJoint Bone Spine, 2007
- Systemic juvenile idiopathic arthritis: diagnosis, management, and outcomeNature Clinical Practice Rheumatology, 2006
- Long‐term open‐label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular‐course juvenile rheumatoid arthritisArthritis & Rheumatism, 2005
- Juvenile Rheumatoid Arthritis—Madras experienceIndian Journal of Pediatrics, 1996
- Time course of response to nonsteroidal antiinflammatory drugs in juvenile rheumatoid arthritisArthritis & Rheumatism, 1984